Capital Flow Monitor · Sponsors · CIK 1990659
FORE US Bio Inc.
3675 MARKET STREET, PHILADELPHIA, PA, 19104 · 267-641-7575
Biotechnology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$109.6M
Sold
$70.4M
% sold
64.2%
Investors
20
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | D/A ·current | 506(b) | $109.6M | $70.4M | 64.2% | 20 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- William Hinshaw — Executive Officer / Director, Philadelphia, PA
- Erez Chimovits — Director, Philadelphia, PA
- Dieter Weinand — Director, Philadelphia, PA
- Chandra Leo — Director, Philadelphia, PA
-
Rajeev Dadoo — Director, Philadelphia, PA
2 other raises
- SR One Capital Fund III, LP $247.3M of $600.0M · 41.2%
- Synapse Investment, LP $0 of —
-
Giovanni Mariggi — Director, Philadelphia, PA
1 other raise
- Illexcor Therapeutics, Inc. $13.0M of $69.0M · 18.8%
- Michael Byrnes — Executive Officer, Philadelphia, PA
-
Kim Blackwell — Director, Philadelphia, PA
1 other raise
- CHARM Therapeutics Inc. $17.3M of $80.1M · 21.6%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.